Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


Form 10-Q

(Mark One)


ý

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

For the period ended December 31, 2002.

o

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Commission File Number: 0-20289


KEMET CORPORATION
Exact name of registrant as specified in its charter

DELAWARE   57-0923789
(State or other jurisdiction of incorporation or organization)   (IRS Employer Identification No.)

2835 KEMET WAY, SIMPSONVILLE, SOUTH CAROLINA 29681
(Address of principal executive offices, zip code)

864-963-6300
(Registrant's telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: N/A


        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES  ý            NO  o

        Common Stock Outstanding at: January 31, 2003


Title of Each Class

 

Number of Shares Outstanding

Common Stock, $.01 Par Value   86,211,857




Part I—FINANCIAL INFORMATION

ITEM 1—Financial Statements


KEMET CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(Dollars in thousands except per share data)

 
  December 31, 2002
  March 31, 2002
 
ASSETS              
Current assets:              
  Cash and cash equivalents   $ 282,865   $ 234,622  
  Accounts receivable     41,286     22,101  
  Inventories:              
    Raw materials and supplies     102,194     118,527  
    Work in process     48,197     68,318  
    Finished goods     59,499     72,547  
   
 
 
      Total inventories     209,890     259,392  
Prepaid expenses and other current assets     4,110     10,791  
Deferred income taxes     28,595     40,255  
   
 
 
      Total current assets     566,746     567,161  
Property and equipment, net     497,851     539,785  
Intangible assets, net     41,799     41,856  
Other assets     23,861     22,912  
   
 
 
      Total assets   $ 1,130,257   $ 1,171,714  
   
 
 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 
Current liabilities:              
  Accounts payable, trade   $ 52,192   $ 73,057  
  Accrued expenses     34,943     32,252  
  Income taxes payable     758     7,076  
   
 
 
      Total current liabilities     87,893     112,385  
Long-term debt     100,000     100,000  
Other non-current obligations     74,016     48,926  
Deferred income taxes     58,811     55,358  
   
 
 
      Total liabilities     320,720     316,669  

Stockholders' equity:

 

 

 

 

 

 

 
  Common stock, par value $.01, authorized 300,000,000 shares, issued 87,849,419 and 87,783,060 shares at December 31, 2002, and March 31, 2002, respectively     878     878  
  Additional paid-in capital     318,514     321,734  
  Retained earnings     523,452     562,903  
  Accumulated other comprehensive income (loss)     (3,047 )   3,808  
  Treasury stock, at cost (1,641,665 and 1,859,695 shares at December 31, 2002, and March 31, 2002, respectively)     (30,260 )   (34,278 )
   
 
 
      Total stockholders' equity     809,537     855,045  
   
 
 

Commitments and contingencies

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

$

1,130,257

 

$

1,171,714

 
   
 
 

See accompanying notes to consolidated financial statements.

2



KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations

(Dollars in thousands except per share data)

 
  Three months ended December 31,
  Nine months ended December 31,
 
 
  2002
  2001
  2002
  2001
 
Net sales   $ 103,727   $ 117,296   $ 340,827   $ 390,653  

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Cost of goods sold     134,789     119,474     332,451     328,304  
  Selling, general and administrative expenses     13,834     13,887     40,984     41,459  
  Research and development     5,615     5,477     19,330     19,831  
  Restructuring and impairment charges         15,296     16,964     15,296  
   
 
 
 
 
    Total operating costs and expenses     154,238     154,134     409,729     404,890  
   
 
 
 
 
    Operating income (loss)     (50,511 )   (36,838 )   (68,902 )   (14,237 )

Other (income) and expense:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Interest income     (1,100 )   (1,769 )   (3,051 )   (8,391 )
  Interest expense     1,133     1,358     3,233     5,376  
  Other expense (income)     (2,476 )   734     (9,310 )   4,000  
   
 
 
 
 
    Total other expense (income)     (2,443 )   323     (9,128 )   985  
   
Earnings (loss) before income taxes

 

 

(48,068

)

 

(37,161

)

 

(59,774

)

 

(15,222

)

Income tax expense (benefit)

 

 

(16,343

)

 

(10,242

)

 

(20,323

)

 

(2,344

)
   
 
 
 
 
      Net earnings (loss)   $ (31,725 ) $ (26,919 ) $ (39,451 ) $ (12,878 )
   
 
 
 
 

Net earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Basic   ($ 0.37 ) ($ 0.31 ) ($ 0.46 ) ($ 0.15 )
  Diluted   ($ 0.37 ) ($ 0.31 ) ($ 0.46 ) ($ 0.15 )

Weighted-average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Basic     86,099,656     85,916,721     86,113,737     85,792,509  
  Diluted     86,099,656     85,916,721     86,113,737     85,792,509  

See accompanying notes to consolidated financial statements.

3



KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Dollars in thousands)

 
  Nine months ended
December 31,

 
 
  2002
  2001
 
Sources (uses) of cash:              
 
Operating activities:

 

 

 

 

 

 

 
    Net earnings (loss)   $ (39,451 ) $ (12,878 )
    Adjustments to reconcile net earnings to net cash from operating activities:              
      Depreciation, amortization and impairment charges     58,742     70,280  
      Gain on sales of interest rate swaps     (6,925 )    
      Change in operating assets     35,539     42,832  
      Change in liabilities     9,121     (143,570 )
      Tax benefit on stock options exercised     728     1,048  
   
 
 
    Net cash provided (used) by operating activities     57,754     (42,288 )

Investing activities:

 

 

 

 

 

 

 
  Purchases of short-term investments     (14,959 )   (57,818 )
  Proceeds from maturity of short-term investments     14,959     23,245  
  Additions to property and equipment     (17,309 )   (73,400 )
  Proceeds from sale of interest rate swaps     6,925      
  Investment in affiliates     (113 )   (7,207 )
  Other     916     179  
   
 
 
    Net cash used by investing activities     (9,581 )   (115,001 )

Financing activities:

 

 

 

 

 

 

 
  Proceeds from sale of common stock to Employee Savings Plan     903     1,089  
  Proceeds from exercise of stock options     2,668     1,515  
  Proceeds from put options     225     600  
  Put option settlement     (3,726 )    
  Purchases of treasury stock         (10,800 )
   
 
 
    Net cash provided (used) by financing activities     70     (7,596 )
   
 
 
   
Net increase (decrease) in cash

 

 

48,243

 

 

(164,885

)

Cash and cash equivalents at beginning of period

 

 

234,622

 

 

360,758

 
   
 
 

Cash and cash equivalents at end of period

 

$

282,865

 

$

195,873

 
   
 
 

See accompanying notes to consolidated financial statements.

4


Note 1. Basis of Financial Statement Preparation

        The consolidated financial statements contained herein, other than the March 31, 2002, balance sheet, are unaudited and have been prepared from the books and records of KEMET Corporation and its Subsidiaries ("KEMET" or the "Company"). In the opinion of management, the consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. The consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. Although the Company believes that the disclosures are adequate to make the information presented not misleading, it is suggested that these consolidated financial statements be read in conjunction with the audited financial statements and notes thereto included in the Company's fiscal year ending March 31, 2002, Form 10-K. Net sales and operating results for the three- and nine-month periods ended December 31, 2002, are not necessarily indicative of the results to be expected for the full year.

        The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. In consolidation, all significant intercompany amounts and transactions have been eliminated.

        When KEMET Electronics Corporation was formed as a separate entity in 1987, it continued the Union Carbide practice of expensing depreciation and amortization costs in the current period, rather than including such costs as a component of inventory and expensing them through cost of goods sold over time, as required by current generally accepted accounting principles. Beginning with the June 2002 quarter, KEMET included depreciation and amortization as a component of its cost of inventory. The impact of this change on the three-month and nine-month periods ended December 31, 2002, amounted to additional after-tax income of approximately $85,000 and $469,000 or $0.001 and $0.005 per share, respectively. KEMET has also reviewed the financial statements contained in its previously filed 2002 Annual Report on Form 10-K and confirmed that this change would not have resulted in any material changes to those financial statements. In addition, the presentation of the Statement of Operations has been reclassified to include depreciation and amortization expenses of $15.0 million and $16.4 million in cost of goods sold; depreciation of $2.1 million and $2.0 million in selling, general, and administrative expenses; and depreciation of $0.4 million and $0.3 million in research and development expenses in the quarters ended December 31, 2002 and 2001, respectively, and depreciation and amortization expenses of $45.9 million and $48.3 million in cost of goods sold; depreciation of $6.1 million and $5.8 million in selling, general, and administrative expenses; and depreciation of $1.2 million and $0.8 million in research and development expenses in the nine-month periods ended December 31, 2002 and 2001, respectively.

        This change makes KEMET's financial statement presentation more comparable to those of other capacitor manufacturers.

        The Company also converted the cost of a portion of its inventory determined by the last-in, first-out ("LIFO") basis to the first-in, first-out ("FIFO") method during the quarter ended June 30, 2002. The after-tax impact was approximately $544,000 and was not considered material to the consolidated financial statements. Therefore, prior period amounts have not been restated for this change in accounting principle. LIFO was the basis for approximately 6% of inventory costs of certain raw materials at March 31, 2002. After the conversion, 100% of the Company's inventory costs will be determined by the FIFO method.

        See also Note 3.

        Certain prior-year amounts were reclassified to conform to current period presentation.

5



Note 2. Reconciliation of basic earnings (loss) per common share

        In accordance with FASB Statement No. 128, the Company had net losses for each period presented, therefore there are no reconciling items between basic earnings (loss) per share and diluted earnings (loss) per share as presented below.

Computation of Basic and Diluted Earnings (Loss) Per Share
(Dollars in thousands except per share data)

 
  For the three months ended December 31,
 
 
  2002
  2001
 
 
  Loss
(numerator)

  Shares
(denominator)

  Per-
Share
Amount

  Loss
(numerator)

  Shares
(denominator)

  Per-
Share
Amount

 
Basic EPS   $ (31,725 ) 86,099,656   $ (0.37 ) $ (26,919 ) 85,916,721   $ (0.31 )

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
  Stock options                      
  Put options                      
   
 
 
 
 
 
 
Diluted EPS   $ (31,725 ) 86,099,656   $ (0.37 ) $ (26,919 ) 85,916,721   $ (0.31 )
   
 
 
 
 
 
 

 


 

For the nine months ended December 31,


 
 
  2002
  2001
 
 
  Loss
(numerator)

  Shares
(denominator)

  Per-
Share
Amount

  Loss
(numerator)

  Shares
(denominator)

  Per-
Share
Amount

 
Basic EPS   $ (39,451 ) 86,113,737   $ (0.46 ) $ (12,878 ) 85,792,509   $ (0.15 )

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
  Stock options                      
  Put options                      
   
 
 
 
 
 
 
Diluted EPS   $ (39,451 ) 86,113,737   $ (0.46 ) $ (12,878 ) 85,792,509   $ (0.15 )
   
 
 
 
 
 
 

        The quarter and nine months ended December 31, 2002, excluded potentially dilutive securities of approximately 243,000 and 344,000, respectively, in the computation of diluted earnings (loss) per share because the effect would have been anti-dilutive. The quarter and nine months ended December 31, 2001, excluded potentially dilutive securities of approximately 895,000 and 963,000, respectively, in the computation of diluted earnings (loss) per share because the effect would have been anti-dilutive.

Note 3. Goodwill and intangible assets

        In July 2001, the FASB issued Statement of Financial Accounting Standards No. 141, "Business Combinations" (Statement No. 141), and Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets"(Statement No. 142). Statement No. 141 requires that the purchase method of accounting be used for all business combinations initiated after June 30, 2001. Statement No. 141 also specifies criteria that intangible assets acquired in a purchase method business combination must meet in order to be recognized and reported apart from goodwill. Statement No. 142 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment. In addition, any unamortized negative goodwill must be written off at the date of adoption. Statement No. 142 is effective for fiscal years beginning after December 15, 2001, and was adopted by the Company effective April 1, 2002.

        In connection with the adoption of Statement No. 142, the Company completed impairment tests of its goodwill and other identifiable intangible assets including indefinite-lived trademarks, as well as

6



patents and technology that have definite lives and will continue to be amortized. No impairment of assets was noted.

        For purposes of determining the fair value of its trademarks, the Company utilized a discounted cash flow model which considered the costs of royalties in the absence of trademarks owned by the Company.

        For purposes of determining potential impairment of goodwill, the Company aggregated its reporting units as its segments are aggregated to a single reporting segment under Statement No. 131. The Company's publicly traded stock price is utilized as a component of its model for determining fair value in order to evaluate goodwill impairment. Negative goodwill of approximately $661,000 was written off upon adoption of the new standard and was included in "Other income" in the statement of earnings for the quarter ended June 30, 2002, because it was not material.

        The carrying amounts, accumulated amortization, and amortization expense for each of the periods presented are noted below by intangible asset class (in thousands):

 
  December 31, 2002
  March 31, 2002
 
 
  Carrying
Amount

  Accumulated
Amortization

  Carrying
Amount

  Accumulated
Amortization

 
Goodwill   $ 41,630   $ 13,278   $ 41,630   $ 13,278  
Negative goodwill             (921 )   (260 )
Trademarks     10,000     2,819     10,000     2,819  
Patents and technology     12,000     6,211     12,000     5,611  
Other     1,142     665     1,143     548  
   
 
 
 
 
    $ 64,772   $ 22,973   $ 63,852   $ 21,996  
   
 
 
 
 

 


 

Amortization Expense


 
 
  Three months ended
December 31,

  Nine months ended
December 31,

 
 
  2002
  2001
  2002
  2001
 
Goodwill   $   $ 247   $   $ 740  
Negative goodwill         (6 )       (18 )
Trademarks         63         189  
Patents and technology     200     200     600     600  
Other     39     39     118     118  
   
 
 
 
 
    $ 239   $ 543   $ 718   $ 1,629  
   
 
 
 
 

7


        The reconciliation of net loss and loss per share, adjusted to exclude goodwill, trademark, and negative goodwill amortization expense, net of tax, for the three- and nine-month periods ended December 31, 2002 and 2001, is as follows (in thousands, except per share amounts):

 
  Three months ended
December 31,

  Nine months ended
December 31,

 
 
  2002
  2001
  2002
  2001
 
Net income(loss):                          
Reported net income (loss)   $ (31,725 ) $ (26,919 ) $ (39,451 ) $ (12,878 )
  Goodwill amortization, net of tax         158         473  
  Negative goodwill amortization, net of tax         (4 )       (12 )
  Trademark amortization, net of tax         40         121  
   
 
 
 
 
Adjusted net income (loss)   $ (31,725 ) $ (26,725 ) $ (39,451 ) $ (12,296 )
   
 
 
 
 

Basic earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 
Reported basic earnings (loss) per common share   $ (0.37 ) $ (0.31 ) $ (0.46 ) $ (0.15 )
  Goodwill amortization, net of tax                 0.01  
  Negative goodwill amortization, net of tax                  
  Trademark amortization, net of tax                  
   
 
 
 
 
Adjusted basic earnings (loss) per common share   $ (0.37 ) $ (0.31 ) $ (0.46 ) $ (0.14 )
   
 
 
 
 

Diluted earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 
Reported diluted earnings (loss) per common share   $ (0.37 ) $ (0.31 ) $ (0.46 ) $ (0.15 )
  Goodwill amortization, net of tax         0.00         0.01  
  Negative goodwill amortization, net of tax         0.00         0.00  
  Trademark amortization, net of tax         0.00         0.00  
   
 
 
 
 
Adjusted diluted earnings (loss) per common share   $ (0.37 ) $ (0.31 ) $ (0.46 ) $ (0.14 )
   
 
 
 
 

Note 4. Derivatives and Hedging

        The Company uses certain derivative financial instruments to reduce exposures to volatility of foreign currencies and commodities impacting the costs of its products.

Hedging Foreign Currencies

        Certain operating expenses at the Company's Mexican facilities are paid in Mexican pesos. In order to hedge these forecasted cash flows, management purchases forward contracts to buy Mexican pesos for periods and amounts consistent with the related underlying cash flow exposures. These contracts are designated as hedges at inception and monitored for effectiveness on a routine basis. At December 31, 2002, the Company had outstanding forward exchange contracts that mature within approximately fifteen months to purchase Mexican pesos with notional amounts of $78.1 million. The fair values of these contracts at December 31, 2002, totaled $2.8 million, which is recorded as a derivative liability on the Company's balance sheet as other current liabilities. During the next 12 months, approximately $2.8 million of the loss on these contracts is expected to be charged to cost of goods sold. The impact of the changes in fair values of these contracts resulted in other comprehensive gain of $45 thousand and $3.9 million for the three months ended December 31, 2002 and 2001, respectively, and other comprehensive gain (loss) of ($6.6) million and $3.5 million for the nine-month periods ended December 31, 2002 and 2001, respectively.

8



Interest Rates Swaps

        In November 2002, the Company entered into two interest rate swap contracts (the "Swaps") which effectively converted its $100 million aggregate principal amount of 6.66% senior notes to floating-rate debt adjusted semi-annually based on six-month LIBOR plus 3.84%. At December 31, 2002, the fair value of the Swaps, based upon market estimates provided by the counterparties, was approximately $0.9 million and was recorded as a derivative asset on the Company's balance sheet as other assets. These derivative instruments reduced interest expense by approximately $0.2 million for the three- and nine-month periods ended December 31, 2002, respectively, and the mark to m